A Trial of Oral BEZ235 and BKM120 in Combination With Paclitaxel With or Without Trastuzumab

Mise à jour : Il y a 5 ans
Référence : NCT01285466

Femme et Homme

Extrait

The purpose of the trial is to determine the maximum tolerated dose (MTD) of BEZ235 and BKM120 in combination with weekly paclitaxel and weekly paclitaxel/trastuzumab.


Critère d'inclusion

  • Metastatic or Locally Advanced Solid Tumors,


Liens